1. Home
  2. EBS vs SEAT Comparison

EBS vs SEAT Comparison

Compare EBS & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • SEAT
  • Stock Information
  • Founded
  • EBS 1998
  • SEAT 2001
  • Country
  • EBS United States
  • SEAT United States
  • Employees
  • EBS 900
  • SEAT N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • SEAT Industrial Machinery/Components
  • Sector
  • EBS Health Care
  • SEAT Industrials
  • Exchange
  • EBS Nasdaq
  • SEAT Nasdaq
  • Market Cap
  • EBS 353.9M
  • SEAT 366.2M
  • IPO Year
  • EBS 2006
  • SEAT N/A
  • Fundamental
  • Price
  • EBS $6.39
  • SEAT $1.63
  • Analyst Decision
  • EBS Strong Buy
  • SEAT Buy
  • Analyst Count
  • EBS 3
  • SEAT 11
  • Target Price
  • EBS $14.33
  • SEAT $4.49
  • AVG Volume (30 Days)
  • EBS 1.3M
  • SEAT 1.4M
  • Earning Date
  • EBS 08-05-2025
  • SEAT 08-05-2025
  • Dividend Yield
  • EBS N/A
  • SEAT N/A
  • EPS Growth
  • EBS N/A
  • SEAT N/A
  • EPS
  • EBS N/A
  • SEAT N/A
  • Revenue
  • EBS $965,400,000.00
  • SEAT $748,757,000.00
  • Revenue This Year
  • EBS N/A
  • SEAT N/A
  • Revenue Next Year
  • EBS $18.88
  • SEAT $4.42
  • P/E Ratio
  • EBS N/A
  • SEAT N/A
  • Revenue Growth
  • EBS N/A
  • SEAT 0.82
  • 52 Week Low
  • EBS $4.02
  • SEAT $1.44
  • 52 Week High
  • EBS $15.10
  • SEAT $5.78
  • Technical
  • Relative Strength Index (RSI)
  • EBS 60.32
  • SEAT 37.49
  • Support Level
  • EBS $6.53
  • SEAT $1.60
  • Resistance Level
  • EBS $6.98
  • SEAT $1.97
  • Average True Range (ATR)
  • EBS 0.35
  • SEAT 0.11
  • MACD
  • EBS 0.01
  • SEAT 0.01
  • Stochastic Oscillator
  • EBS 84.04
  • SEAT 6.76

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

Share on Social Networks: